- Home
- CRIS
CRIS
Curis Inc.
as 06-26-2025 4:00pm EST
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
| Founded: | 2000 | Country: | United States |
| Employees: | N/A | City: | LEXINGTON |
| Market Cap: | 21.3M | IPO Year: | 2000 |
| Target Price: | $16.50 | AVG Volume (30 days): | 75.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -6.03 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.02 - $8.29 | Next Earning Date: | 07-31-2025 |
| Revenue: | $11,202,000 | Revenue Growth: | 14.17% |
| Revenue Growth (this year): | -1.41% | Revenue Growth (next year): | 10.67% |
Latest Curis Inc. News
CRIS Breaking Stock News: Dive into CRIS Ticker-Specific Updates for Smart Investing
GOBankingRates
a month ago
7 Luxury Vehicles Expected To Skyrocket in Price Due To Trump’s Tariffs
GOBankingRates
a month ago
3 International Vacations That Are Cheaper Than an iPhone
GOBankingRates
a month ago
Suze Orman’s 5 Best Tips for Saving Money Even When Living Paycheck to Paycheck
Yahoo Finance
a month ago
This week in Trumponomics: Too bad TACO isn’t true
The Guardian
a month ago
Starmer says Farage would spook the City and give us Truss 2 – he could be right
Yahoo Finance Video
a month ago
AI ecosystem isn't just Nvidia: Unlock it further with this ETF
Benzinga
a month ago
Is Dave Ramsey's Home Buying Advice Realistic For The Average Homeowner?
Reuters
a month ago
Ford recalls more than 29,000 vehicles in the US, NHTSA says
Compare CRIS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CRIS Curis Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.